Résultats de la recherche
10
Tout
Rechercher les filtres
Mot-clé
pain
[Latest] Global Elastomeric Infusions Pumps Market Size/Share Worth USD 1,369.81 Million by 2034 at a 7.28% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
20 mars 2025 15h30 HE
|
Custom Market Insights
Austin, TX, USA, March 21, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Elastomeric Infusions Pumps Market Size, Trends and Insights By Product...
Dogwood Therapeutics, Inc. Announces Pricing of $4.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
13 mars 2025 09h00 HE
|
Dogwood Therapeutics, Inc.
Proceeds from today’s financing, when added to existing cash, fund operations through Q1 2026 The Company is planning to announce interim data from its ongoing Halneuron® Phase 2b chemotherapy...
Dogwood Therapeutics, Inc. Announces Conversion of Existing $19.5M in Debt to Equity, Strengthening Balance Sheet Moving Forward
12 mars 2025 08h30 HE
|
Dogwood Therapeutics, Inc.
ATLANTA, March 12, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (“Dogwood” or the “Company”), a development-stage biopharmaceutical company focused on advancing first-in-class,...
Petvivo Holdings, Inc. and Digital Landia Corp. Announce Groundbreaking Strategic Alliance Agreement to Pioneer Agentic AI for Animal Communication
03 mars 2025 08h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, March 03, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) (the "Company" or “PetVivo”) an emerging biomedical device company focused on the...
Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.
21 févr. 2025 07h00 HE
|
Nutriband Inc.
Issued new Trademark
PetVivo Reports Fiscal Q3 2025 Results
14 févr. 2025 15h10 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Feb. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW), a leading biomedical company delivering innovative therapeutics and medical devices for...
PetVivo Signs Exclusive Sales and Marketing Agreement with VetStem for PrecisePRP® Canine and Equine Products
14 févr. 2025 08h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, Feb. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW), a leader in innovative veterinary medical solutions, has entered into an Exclusive License...
Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
13 févr. 2025 07h00 HE
|
Nutriband Inc.
Partnership Agreement
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2024
11 févr. 2025 10h15 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Feb. 11, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV and OTCPINK: PETVW), an emerging biomedical device company focused on the commercialization of innovative...
Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board
11 févr. 2025 09h00 HE
|
Nutriband Inc.
ORLANDO, Fla., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (the “Company”)(NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced World and European...